Molecular classification of the dementias

Lancet

Volumn 355, Issue 9204, 2000, Pages 626-

  Mann, David M A ^a   McDonagh, Andrea M ^a   Snowden, Julies ^b   Neary, David ^b   Pickering Brown, Stuart M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AT 8; CP 13; PROTEIN ANTIBODY; TAU PROTEIN; UNCLASSIFIED DRUG;

APHASIA; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOTOR NEURON DISEASE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

EID: 0342470539     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)05207-1     Document Type: Article

References (4)

1. Hardy J., Duff K., Gwinn-Hardy K., Perez-Tur J., Hutton M. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nature Neurosci. 1:1998;355-358.
2. Tolnay M., Probst A. Tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol. 25:1999;171-187.
3. Mann D.M.A., South P., Snowden J.S., Neary D. Dementia of frontal lobe type neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry. 56:1993;605-614.
4. Hutton M., Lendon C.L., Rizzu P.et al. Coding and 5′ splice mutations in tau associated with inherited dementia (FTDP-17). Nature. 393:1998;702-705.